Farnesyltransferase Inhibitors in Cancer Therapy
DOI: 10.1385/1-59259-013-6:115
|View full text |Cite
|
Sign up to set email alerts
|

From Random Screening of Chemical Libraries to the Optimization of FPP-Competitive Inhibitors of Farnesyltransferase

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Publication Types

Select...
1

Relationship

1
0

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 0 publications
0
1
0
Order By: Relevance
“…A major obstacle related to this strategy is the lack of selectivity of inhibitors for FT over geranylgeranyltransferase (GGT). Among the numerous series of compounds optimized toward an acceptable selectivity, the benzo[ f ]perhydroisoindole (BPHI) class (studied by Aventis) is one of the most efficient in vitro . Compounds such as RPR 115135 ( 1 ; Figure ) show acceptable cellular potency with moderate in vivo activity.…”
Section: Introductionmentioning
confidence: 99%
“…A major obstacle related to this strategy is the lack of selectivity of inhibitors for FT over geranylgeranyltransferase (GGT). Among the numerous series of compounds optimized toward an acceptable selectivity, the benzo[ f ]perhydroisoindole (BPHI) class (studied by Aventis) is one of the most efficient in vitro . Compounds such as RPR 115135 ( 1 ; Figure ) show acceptable cellular potency with moderate in vivo activity.…”
Section: Introductionmentioning
confidence: 99%